MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
Core Solutions, a leader in AI-powered solutions for behavioral health and development, has introduced Cx360 Enterprise: The Intelligent Care Record, a platform designed to modernize data management and clinical workflows in behavioral health settings. The system integrates artificial intelligence to help providers capture, organize, and analyze patient information more effectively. The platform is intended to support clinical decision-making, streamline documentation, and improve coordination across care teams. Focused on behavioral health, the platform integrates AI to record and reflect on how care is delivered to individuals, providing healthcare workers with effective ways to manage and configure workflows as well as gain valuable and ethical insights.
More
Posted by MedCloudInsider Editors on 04/13/20260 comments
Ada Health, a clinical expertise and AI insights-driven service provider, announced it has secured a patent for a clinical layer designed to make large language models safer for use in healthcare applications. The technology, Ada's hybrid clinical AI architecture, acts as an intermediary between AI models and clinical use cases, applying medical validation, safety checks, and contextual controls to AI-generated outputs. The goal is to reduce risks associated with using general-purpose language models in clinical decision support and patient interactions. Ada's reasoning engine acts as a guardrail to improve accuracy and preserve rigor, offering a fully auditable clinical reasoning system.
More
Posted by MedCloudInsider Editors on 04/13/20260 comments
Clinical AI, a healthcare technology company developing AI solutions to improve clinical trial execution, has announced the launch of its MAIA Prescreening solution on the Google Cloud Marketplace, targeting improved efficiency in clinical trial recruitment. The launch enables healthcare organizations to deploy AI-driven patient screening workflows directly through Google Cloud. The platform uses artificial intelligence to analyze patient data and identify candidates who may qualify for clinical studies. By automating prescreening, the system is designed to help research organizations reduce manual review processes and accelerate enrollment timelines.
More
Posted by MedCloudInsider Editors on 04/06/20260 comments
GC Biopharma, a biopharmaceutical company focused on manufacturing plasma derivatives, announced a new technology designed to improve the safety profile of intravenous immunoglobulin (IVIG) therapies by detecting prothrombotic impurities. The method enhances its ability to identify trace impurities that may increase the risk of blood clotting in patients receiving IVIG treatments. These therapies are widely used to treat immune deficiencies and autoimmune conditions, making safety a critical concern in manufacturing and quality control. The enhanced assay incorporates a selective IgG Blocker, suppressing non-specific protein reactions ensuring a precise measurement of FXI regardless of the IgG concentration.
More
Posted by MedCloudInsider Editors on 04/06/20260 comments
Lunit, a leader in clinical AI-cancer diagnostics, and CellCarta, a global CRO laboratory, announced a strategic collaboration aimed at accelerating the use of artificial intelligence in digital pathology for companion diagnostic (CDx) development. The partnership will combine Lunit’s AI-based image analysis technology with CellCarta’s laboratory and biomarker services. The goal is to support pharmaceutical companies in developing companion diagnostics that help match patients with targeted therapies based on biomarker data. The collaboration aims to integrate Lunit SCOPE AI digital pathology products with CellCarta workflows to support biomarker strategy, image analysis and CDx readiness.
More
Posted by MedCloudInsider Editors on 03/30/20260 comments
Atlantic Health, a leading not-for-profit health care system, is using artificial intelligence agents from Artera, an agentic healthcare company, to improve colonoscopy screening rates and address gaps in preventive care. The AI agents are designed to engage patients through automated outreach, helping identify individuals due for screening and encouraging them to schedule appointments. The system uses patient data and communication workflows to support follow-ups and reduce missed screenings. Preparation for a colonoscopy can be complex and overwhelming, leading to patient confusion and high cancellation rates. Artera's AI-agents simplify this process with a standardized, AI-driven and digital-first experience.
More
Posted by MedCloudInsider Editors on 03/30/20260 comments
Perplexity and b.well Connected Health, a data-rich digital health platform, announced a partnership to integrate verified health data into AI-powered search, with the goal of improving the accuracy and personalization of health-related responses. The integration will allow Perplexity’s AI search platform to draw on b.well’s curated health data, which includes clinical records, care information and wellness data. The approach is intended to provide users with more relevant and personalized health insights while maintaining data accuracy.
More
Posted by MedCloudInsider Editors on 03/23/20260 comments
Function, a proactive health platform, has expanded its portfolio of AI connectors with a new integration for Perplexity Health, designed to bring health-related insights into enterprise applications. The connector enables organizations to incorporate AI-driven health search capabilities into workflows by linking Perplexity’s platform with Function’s integration layer. The goal is to allow users to access and act on health information within existing systems without switching between tools. The connector is aimed at allowing members to securely connect lab results with clinician-reviewed summaries to Perplexity so their data is available in AI tools as needed.
More
Posted by MedCloudInsider Editors on 03/23/20260 comments
XRlabs, a surgical intelligence company, announced what it said is the first human use of a physical artificial intelligence system integrated with the ORBEYE exoscope, powered by NVIDIA Jetson Thor. The system applies AI models directly within a surgical imaging environment to support real-time analysis during procedures. By running AI at the edge, the platform is designed to process visual data locally, reducing latency and enabling faster insights for clinicians. Future developments planned include intelligent exoscope automation, real-time surgical video integration, intraoperative scene understanding and immersive stereoscopic viewing.
More
Posted by MedCloudInsider Editors on 03/18/20260 comments
Sartorius, a biopharmaceutical laboratory, has introduced a next-generation platform, the Eveo Cell Therapy Platform, aimed at improving efficiency and scalability in cell therapy production. The platform is designed to integrate key steps in the manufacturing process, helping organizations manage complex workflows involved in developing and producing cell-based therapies. The system focuses on improving process consistency, reducing manual intervention and enabling better control over production environments.
More
Posted by MedCloudInsider Editors on 03/18/20260 comments
Mentis Care, an AI-driven neuromonitoring company, announced a research collaboration with Emory University aimed at developing artificial intelligence systems that can detect and predict epileptic seizures using multiple types of neurological data. The project will focus on creating channel-agnostic AI models capable of analyzing signals from different monitoring technologies, including electroencephalography and other neurological data sources. The goal is to improve seizure detection accuracy and enable earlier identification of patterns that may indicate an impending seizure. Improvement in even five minutes of warning times for seizure detection is vital for patients, which is the aim behind Mentis Care building the technology powered by AI to solve this.
More
Posted by MedCloudInsider Editors on 03/16/20260 comments
Caris Life Sciences, a next-gen AI TechBio company, has introduced a new capability within its Caris AI Insights platform designed to help clinicians identify early resistance to platinum-based chemotherapy in ovarian cancer patients (HGSOC). The tool analyzes molecular and genomic data to detect patterns associated with platinum resistance, a common challenge in ovarian cancer treatment. Identifying resistance earlier could help clinicians adjust treatment strategies before the disease progresses. Harnessing AI across comprehensive real-world databases, Caris aims to accelerate biomarker discovery and enhance therapeutic decision-making of more personalized cancer treatments.
More
Posted by MedCloudInsider Editors on 03/16/20260 comments